Bridge Bio News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Bridge Bio. Real-time updates on events, politics, business and more.

Perioperative Durvalumab Does Not Impact Surgical Outcomes in NSCLC

September 14, 2023

Perioperative durvalumab does not adversely impact surgical outcomes in patients with resectable non-small cell lung cancer, data suggest.

Tetsuya Mitsudomi Eli Lilly Boehringer Ingelheim Bristol Myers Squibb Mono Pharmaceuticals Guardant Health

Source: cancertherapyadvisor.com

AI Deployed in Lung Disease Trial

September 8, 2022

U.K. medtech Brainomix is partnering with South Korean Bridge Bio to deploy AI in a Phase II trial of the investigational drug BBT-877 in progressive lung disease.

United States United Kingdom City Of Peter George Biotherapeutics Inc University Of Oxford

Source: insideprecisionmedicine.com

Lexaria Bioscience Corp.: Lexaria Discusses Valuation Metrics for Biotech Industry

August 11, 2022

Third Party Analysis for Biotech and Pharma IndustriesKELOWNA, BC / ACCESSWIRE / August 11, 2022 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator

Raphael Rottgen George Jurcic Lexaria Bioscience Corp Drug Administration Pharma Industries Third Party Analysis For Biotech

Source: finanznachrichten.de

Ionis, AstraZeneca change a key trial, fueling more questions about a genetic heart disease

May 2, 2022

BioPharma

Bio Pharma Stifel Matteis Paul Matteis Alnylam Pharmaceuticals Drug Administration Ionis Pharmaceuticals

Source: biopharmadive.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation